The term “Ebrutiniub” appears to be a typo for the drug Ibrutinib, and its intermediate, 3-amino-4-cyano-5-(4-phenoxyphenyl)pyrazole (CAS No. 330792-70-6), is a chemical used in the synthesis of this medication. Ibrutinib is an oral medication that is used to treat various forms of cancer, such as chronic lymphocytic leukemia, mantle cell lymphoma, and Waldenström's macroglobulinemia.. CAS No: - 330792-70-6
| Molecular Formula: | C₁₆H₁₂N₄O |
| Molecular Weight: | 276.29 g/mol |
| Appearance: | Typically supplied as a white to off-white or light yellow powder. |
| Common Grade: | ≥98.0% by HPLC. |
| High Grade: | ≥99.0% by HPLC. |
| Solubility: | Slightly soluble in DMSO (dimethyl sulfoxide). |